A modified poisson regression approach to prospective studies with binary data
G Zou - American journal of epidemiology, 2004 - academic.oup.com
Relative risk is usually the parameter of interest in epidemiologic and medical studies. In
this paper, the author proposes a modified Poisson regression approach (ie, Poisson …
this paper, the author proposes a modified Poisson regression approach (ie, Poisson …
C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review …
Objectives: Persistent disease activity is associated with a poor prognosis in inflammatory
bowel disease (IBD). Therefore, monitoring of patients with intent to suppress subclinical …
bowel disease (IBD). Therefore, monitoring of patients with intent to suppress subclinical …
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
Background Conventional management of Crohn's disease features incremental use of
therapies. However, early combined immunosuppression (ECI), with a TNF antagonist and …
therapies. However, early combined immunosuppression (ECI), with a TNF antagonist and …
[HTML][HTML] The challenge of indication extrapolation for infliximab biosimilars
A biosimilar is intended to be highly similar to a reference biologic such that any differences
in quality attributes (ie, molecular characteristics) do not affect safety or efficacy. Achieving …
in quality attributes (ie, molecular characteristics) do not affect safety or efficacy. Achieving …
STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statement
Making sense of rapidly evolving evidence on genetic associations is crucial to making
genuine advances in human genomics and the eventual integration of this information in the …
genuine advances in human genomics and the eventual integration of this information in the …
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease
…, F Saibil, F Anderson, A Donner, CJ Wong, G Zou… - Gastroenterology, 2014 - Elsevier
Background & Aims Methotrexate and infliximab are effective therapies for Crohn's disease (CD).
In the combination of maintenance methotrexate-infliximab trial, we evaluated the …
In the combination of maintenance methotrexate-infliximab trial, we evaluated the …
Development and validation of a histological index for UC
Objective Although the Geboes score (GS) and modified Riley score (MRS) are commonly
used to evaluate histological disease activity in UC, their operating properties are unknown. …
used to evaluate histological disease activity in UC, their operating properties are unknown. …
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
…, P Munkholm, U Mittmann, D King, CJ Wong, G Zou… - Gastroenterology, 2013 - Elsevier
BACKGROUND & AIMS: Interobserver differences in endoscopic assessments contribute to
variations in rates of response to placebo in ulcerative colitis (UC) trials. We investigated …
variations in rates of response to placebo in ulcerative colitis (UC) trials. We investigated …
Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care
Background— A barrier to statin therapy is myopathy associated with elevated systemic
drug exposure. Our objective was to examine the association between clinical and …
drug exposure. Our objective was to examine the association between clinical and …
Comparison of fracture risk prediction among individuals with reduced and normal kidney function
Results There were 320 individuals with an eGFR< 60 ml/min per 1.73 m 2 and 1787 with
an eGFR≥ 60 ml/min per 1.73 m 2. The mean age was 67±10 years and 71% were women. …
an eGFR≥ 60 ml/min per 1.73 m 2. The mean age was 67±10 years and 71% were women. …